Cargando…

Not only ACE2—the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19

Detalles Bibliográficos
Autores principales:	Kyrou, Ioannis, Randeva, Harpal S., Spandidos, Demetrios A., Karteris, Emmanouil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812344/ https://www.ncbi.nlm.nih.gov/pubmed/33462185 http://dx.doi.org/10.1038/s41392-020-00460-9

Ejemplares similares

Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19
por: Davies, Julie, et al.
Publicado: (2020)

Host cell entry mediators implicated in the cellular tropism of SARS-CoV-2, the pathophysiology of COVID-19 and the identification of microRNAs that can modulate the expression of these mediators (Review)
por: Katopodis, Periklis, et al.
Publicado: (2022)

COVID-19 and SARS-CoV-2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease
por: Katopodis, Periklis, et al.
Publicado: (2021)

Pan-cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS-CoV-2 infection leading to COVID-19
por: Katopodis, Periklis, et al.
Publicado: (2020)

Co-expression of peripheral olfactory receptors with SARS-CoV-2 infection mediators: Potential implications beyond loss of smell as a COVID-19 symptom
por: Kerslake, Rachel, et al.
Publicado: (2020)

The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2021)

Protein expression of transmembrane protease serine 4 in the gastrointestinal tract and in healthy, cancer, and SARS-CoV-2 infected lungs
por: Kerslake, Rachel, et al.
Publicado: (2022)

Characterization of peptide binding to the SARS-CoV-2 host factor neuropilin
por: Jobe, Amie, et al.
Publicado: (2021)

ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1
por: Simonetti, Boris, et al.
Publicado: (2022)

Is There a Link between Bisphenol A (BPA), a Key Endocrine Disruptor, and the Risk for SARS-CoV-2 Infection and Severe COVID-19?
por: Zahra, Aeman, et al.
Publicado: (2020)

In silico drug repositioning against human NRP1 to block SARS-CoV-2 host entry
por: GÜL, Şeref
Publicado: (2021)

Transplacental transmission of SARS-CoV-2 infection via NRP1
por: El-Arabey, Amr Ahmed, et al.
Publicado: (2021)

Targeting neuropilins as a viable SARS‐CoV‐2 treatment
por: Sarabipour, Sarvenaz, et al.
Publicado: (2021)

Characterization of SARS-CoV-2 dynamics in the host
por: Abuin, Pablo, et al.
Publicado: (2020)

The Potential Intermediate Hosts for SARS-CoV-2
por: Zhao, Jie, et al.
Publicado: (2020)

Mapping host restriction of SARS-CoV-2
por: Gea-Mallorquí, Ester
Publicado: (2020)

Host variations in SARS-CoV-2 infection
por: ALTIOK, Doruk, et al.
Publicado: (2021)

Host Manipulation Mechanisms of SARS-CoV-2
por: Massey, Steven E.
Publicado: (2021)

SARS-CoV-2 vaccination in the immunocompromised host
por: Connolly, Caoilfhionn M., et al.
Publicado: (2022)

Host genomics of SARS-CoV-2 infection
por: Redin, Claire, et al.
Publicado: (2022)

SARS-CoV-2 and the host-immune response
por: Maison, David P., et al.
Publicado: (2023)

SARS-CoV-2 rewires host chromatin
por: Du Toit, Andrea
Publicado: (2023)

Abrogation of SARS-CoV-2 interaction with host (NRP1) neuropilin-1 receptor through high-affinity marine natural compounds to curtail the infectivity: A structural-dynamics data
por: Humayun, Fahad, et al.
Publicado: (2022)

Prevention of host-to-host transmission by SARS-CoV-2 vaccines
por: Mostaghimi, Darius, et al.
Publicado: (2022)

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
por: Cantuti-Castelvetri, Ludovico, et al.
Publicado: (2020)

Dataset of mutational analysis, miRNAs targeting SARS-CoV-2 genes and host gene expression in SARS-CoV and SARS-CoV-2 infections
por: Sardar, Rahila, et al.
Publicado: (2020)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
por: Kim, Kwang Su, et al.
Publicado: (2021)

Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2
por: Wu, Lili, et al.
Publicado: (2020)

CRISPRing for host genes regulating SARS-CoV-2
por: Lu, Fangfang, et al.
Publicado: (2020)

Host-directed editing of the SARS-CoV-2 genome
por: Mourier, Tobias, et al.
Publicado: (2021)

Evidence for SARS-CoV-2 Infection of Animal Hosts
por: Abdel-Moneim, Ahmed S., et al.
Publicado: (2020)

SARS-CoV-2: virus dynamics and host response
por: Chen, Yu, et al.
Publicado: (2020)

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
por: Choi, Bina, et al.
Publicado: (2020)

Host proviral and antiviral factors for SARS-CoV-2
por: Lv, Lu, et al.
Publicado: (2021)

Host ADP-ribosylation and the SARS-CoV-2 macrodomain
por: Hoch, Nicolas C.
Publicado: (2021)

SARS-CoV-2 within-host diversity and transmission
por: Lythgoe, Katrina A., et al.
Publicado: (2021)

The sound of host-SARS-CoV-2 molecular interactions
por: de la Fuente, José, et al.
Publicado: (2021)

SARS-CoV-2 Restructures the Host Chromatin Architecture
por: Wang, Ruoyu, et al.
Publicado: (2021)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

Dynamics of host immune responses to SARS-CoV-2
por: Taherkhani, Reza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_somrq0dsq1bbkbkbf7fm4631m0